ADAGE CAPITAL PARTNERS GP, L.L.C.
Position in FULC — Fulcrum Therapeutics, Inc.
CIK 1165408
Boston, MA
Position in FULC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,320,000
+$4,252,000 QoQ
Shares Held
2,000,000
+400.0% QoQ
Ownership
2.62%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 154 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. FULC ranks #84 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in FULC
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,320,000 | 2,000,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,068,000 | 400,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,227,000 | 1,700,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $22,374,400 | 2,432,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $31,572,320 | 4,589,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,640,000 | 3,000,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,100,000 | 3,000,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,140,000 | 2,000,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,860,000 | 300,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,444,623 | 1,106,422 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,168,348 | 1,506,422 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,684,513 | 2,406,422 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,611,192 | 2,306,422 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $5,148,302 | 1,806,422 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,153,600 | 1,120,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,678,800 | 1,320,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,323,000 | 270,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $46,117,500 | 1,950,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $30,426,800 | 1,720,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $33,287,800 | 1,180,000 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||